Table 3.
Antioxidant capacity and lipid peroxidation of subjects with lutein or lutein plus green tea extract1
Lutein (n=20) | Lutein + Green tea extract (n=20) | |||||
---|---|---|---|---|---|---|
day 0 | day 29 | day 113 | day 0 | day 29 | day 113 | |
TAP (Q value) 1 | 2.41 ± 0.43 | 2.22 ± 0.65 | 2.51 ± 0.22 | 2.56 ± 0.37 | 2.47 ± 0.58 | 2.65 ± 0.20 |
MDA (μM) 2 | 0.50 ± 0.08 | 0.52 ± 0.11 | 0.52 ± 0.09 | 0.54 ± 0.13 | 0.52 ± 0.08 | 0.52 ± 0.10 |
MDA ratio3 | 8.16 ± 4.27 | 8.51 ± 3.55 | 6.95 ± 1.47 | 8.99 ± 6.01 | 9.11 ± 4.85 | 9.24 ± 4.57 |
8-isoprostane (nM) 4 | 1.89 ± 1.92 | 1.34 ± 1.32 | 1.42 ± 0.75 | 2.51 ± 2.41 | 2.59 ± 2.28 | 2.87 ± 2.70 |
t-HODE (μM)5 | 0.37 ± 0.09 | 0.37 ±0.11 | 0.38 ± 0.09 | 0.31 ± 0.09 | 0.36 ± 0.11 | 0.37 ± 0.09 |
ZE/EE6 | 1.46 ± 0.39 | 1.55 ± 0.40 | 1.46 ± 0.41 | 1.51 ± 0.29 | 1.59 ± 0.40 | 1.53± 0.50 |
All values are Means ± SD, No significant difference among groups (One-way repeated measures ANOVA with Tukey multiple comparison was performed. When an equal variance test failed, Friedman repeated measures analysis of variance on ranks with a Tukey multiple comparison test was used)
TAP: Total antioxidant performance
MDA: malondialdehyde
MDA-AMVN/MDA: 2,2′-Azobis(2,4-dimethyl-valenomitrile) induced malondialdehyde/malondialdehyde
t8iso-P: Total 8-iso-prostaglandin F2α
tHODE: Total hydroxyloctadecadienoic acid
ZE/EE: The raito of stereo-isomers, 9,13-(Z/E)-HODE/9,13-(E,E)-HODE; 9,13 (Z/E)-HODE = 9-(Z/E)-HODE & 13-(Z/E)-HODE, 9, 13-(E/E)-HODE = 9-(E/E)-HODE & 13-(E/E)-HODE